Clinical Trial Update: A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations [Phase 2]

View source ↗

Summary

Phase 2 study evaluating NPSP795 effects on calcium-sensing receptor in autosomal dominant hypocalcemia, with PTH and calcium outcomes; study completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Hypocalcemia

Drugs mentioned

• NPSP795

Snippet

Sponsor: Shire | Conditions: Autosomal Dominant Hypocalcemia (ADH) | Phase 2 | Status: COMPLETED | Results posted: 2016-12-21